Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Scolr Pharma, Inc. (DDD) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Scolr Pharma, Inc.. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 934936.
Total stock buying since 2005: $440,158.
Total stock sales since 2005: $708,420.
Total stock option exercises since 2005: $243,201.
▪ Recent SEC 13D filings for all companies
▪ Funds & ETFs holding DDD
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2009 | 2,500 | $625 | 0 | $0 | 0 | $0 |
| 2008 | 48,000 | $45,369 | 39,526 | $39,526 | 20,000 | $20,000 |
| 2007 | 97,600 | $189,089 | 0 | $0 | 87,000 | $68,035 |
| 2006 | 30,000 | $150,463 | 120,600 | $580,144 | 191,667 | $155,166 |
| 2005 | 17,500 | $54,612 | 25,000 | $88,750 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2009-03 | 2,500 | $625 | 0 | $0 | 0 | $0 |
| 2008-11 | 38,000 | $34,620 | 0 | $0 | 0 | $0 |
| 2008-05 | 10,000 | $10,749 | 0 | $0 | 0 | $0 |
| 2008-03 | 0 | $0 | 39,526 | $39,526 | 0 | $0 |
| 2008-01 | 0 | $0 | 0 | $0 | 20,000 | $20,000 |
| 2007-12 | 35,500 | $46,521 | 0 | $0 | 10,000 | $5,600 |
| 2007-05 | 5,000 | $12,010 | 0 | $0 | 0 | $0 |
| 2007-03 | 57,100 | $130,558 | 0 | $0 | 27,000 | $9,935 |
| 2007-02 | 0 | $0 | 0 | $0 | 50,000 | $52,500 |
| 2006-11 | 10,000 | $48,349 | 0 | $0 | 15,000 | $12,000 |
| 2006-08 | 0 | $0 | 54,000 | $261,852 | 50,000 | $52,500 |
| 2006-07 | 0 | $0 | 3,900 | $18,731 | 0 | $0 |
| 2006-06 | 7,500 | $38,000 | 62,700 | $299,561 | 0 | $0 |
| 2006-05 | 12,500 | $64,114 | 0 | $0 | 66,667 | $36,666 |
| 2006-04 | 0 | $0 | 0 | $0 | 60,000 | $54,000 |
| 2005-06 | 17,500 | $54,612 | 25,000 | $88,750 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-03-17 | Taglich Michael N (Director) | Buy | 2,500 | .25 | 625 |
| 2008-11-19 | Wilds Daniel O (Chief Executive Officer) | Buy | 5,000 | .90 | 4,500 |
| 2008-11-12 | Mitchel Alan M (Sr. VP - Chief Legal Officer) | Buy | 3,000 | .89 | 2,670 |
| 2008-11-12 | Wilds Daniel O (Chief Executive Officer) | Buy | 5,000 | .89 | 4,450 |
| 2008-11-11 | Jeffrey Reich (Director) | Buy | 25,000 | .92 | 23,000 |
| 2008-05-30 | Wilds Daniel O (Chief Executive Officer) | Buy | 2,500 | 1.04 | 2,612 |
| 2008-05-30 | Levy Richard M (Chief Financial Officer) | Buy | 5,000 | 1.09 | 5,475 |
| 2008-05-07 | Wilds Daniel O (Chief Executive Officer) | Buy | 2,500 | 1.06 | 2,662 |
| 2008-03-11 | Caudill Randall L W (Director) | Sale | 39,526 | 1.00 | 39,526 |
| 2008-01-22 | Lucas Herbert L Jr (Director) | Option Ex | 20,000 | 1.00 | 20,000 |
| 2007-12-17 | Turner Stephen (Chief Technology Officer) | Option Ex | 10,000 | .56 | 5,600 |
| 2007-12-11 | Levy Richard M (Chief Financial Officer) | Buy | 2,000 | 1.21 | 2,420 |
| 2007-12-10 | Mitchel Alan M (Sr. VP - Chief Legal Officer) | Buy | 3,116 | 1.24 | 3,848 |
| 2007-12-10 | Levy Richard M (Chief Financial Officer) | Buy | 2,000 | 1.25 | 2,500 |
| 2007-12-07 | Mitchel Alan M (Sr. VP - Chief Legal Officer) | Buy | 4,384 | 1.31 | 5,743 |
| 2007-12-07 | Levy Richard M (Chief Financial Officer) | Buy | 2,000 | 1.34 | 2,680 |
| 2007-12-07 | Taglich Michael N (Director) | Buy | 10,000 | 1.32 | 13,200 |
| 2007-12-06 | Wilds Daniel O (Chief Executive Officer) | Buy | 10,000 | 1.34 | 13,450 |
| 2007-12-06 | Levy Richard M (Chief Financial Officer) | Buy | 2,000 | 1.34 | 2,680 |
| 2007-05-16 | Wilds Daniel O (Director) | Buy | 5,000 | 2.40 | 12,010 |
| 2007-03-20 | Mitchel Alan M (Chief Legal Officer) | Buy | 2,500 | 2.40 | 6,000 |
| 2007-03-19 | Lucas Herbert L Jr (Director) | Option Ex | 20,000 | .32 | 6,400 |
| 2007-03-16 | Turner Stephen (V.P., Chief Technical Officer) | Option Ex | 7,000 | .51 | 3,535 |
| 2007-03-16 | Wilds Daniel O (Director) | Buy | 10,000 | 2.24 | 22,400 |
| 2007-03-16 | Levy Richard M (Chief Financial Officer) | Buy | 14,600 | 2.23 | 32,558 |
| 2007-03-16 | Taglich Michael N (Director) | Buy | 30,000 | 2.32 | 69,600 |
| 2007-02-02 | Fassihi Reza (Director) | Option Ex | 50,000 | 1.05 | 52,500 |
| 2006-11-14 | Taglich Michael N (Director) | Buy | 5,000 | 4.90 | 24,500 |
| 2006-11-13 | Wilds Daniel O (President and CEO) | Buy | 5,000 | 4.77 | 23,849 |
| 2006-11-07 | Lucas Herbert L Jr (Director) | Option Ex | 15,000 | .80 | 12,000 |
| 2006-08-28 | Fassihi Reza (Director) | Sale | 4,000 | 4.97 | 19,880 |
| 2006-08-25 | Fassihi Reza (Director) | Sale | 30,000 | 4.83 | 144,900 |
| 2006-08-24 | Fassihi Reza (Director) | Sale | 8,000 | 4.83 | 38,648 |
| 2006-08-23 | Fassihi Reza (Director) | Sale | 8,000 | 4.90 | 39,184 |
| 2006-08-08 | Fassihi Reza (Director) | Option Ex | 50,000 | 1.05 | 52,500 |
| 2006-07-05 | Fassihi Reza (Director) | Sale | 3,900 | 4.80 | 18,731 |
| 2006-06-30 | Fassihi Reza (Director) | Sale | 21,800 | 4.72 | 102,896 |
| 2006-06-29 | Fassihi Reza (Director) | Sale | 22,900 | 4.78 | 109,347 |
| 2006-06-28 | Fassihi Reza (Director) | Sale | 18,000 | 4.85 | 87,318 |
| 2006-06-13 | Wilds Daniel O (Director) | Buy | 1,000 | 4.93 | 4,930 |
| 2006-06-12 | Wilds Daniel O (President and CEO) | Buy | 1,500 | 4.98 | 7,470 |
| 2006-06-08 | Taglich Michael N (Director) | Buy | 5,000 | 5.12 | 25,600 |
| 2006-05-23 | Fassihi Reza (Director) | Option Ex | 66,667 | .55 | 36,666 |
| 2006-05-19 | Wilds Daniel O (President and CEO) | Buy | 2,500 | 5.04 | 12,600 |
| 2006-05-16 | Wilds Daniel O (President and CEO) | Buy | 5,000 | 5.24 | 26,215 |
| 2006-05-16 | Taglich Michael N (Director) | Buy | 5,000 | 5.06 | 25,299 |
| 2006-04-19 | Lucas Herbert L Jr (Director) | Option Ex | 60,000 | .90 | 54,000 |
| 2005-06-08 | Wilds Daniel O (PRESIDENT AND CEO) | Buy | 2,500 | 3.25 | 8,112 |
| 2005-06-06 | Taglich Michael N (Director) | Buy | 10,000 | 3.10 | 31,000 |
| 2005-06-01 | Howard David T (Director) | Sale | 25,000 | 3.55 | 88,750 |
Insider trading activities including stock purchases, stock sales, and option exercises of DDD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Scolr Pharma, Inc. (symbol DDD, CIK number 934936) see the Securities and Exchange Commission (SEC) website.